← Back to Search

Emergency Department Nurses for Intravenous Access

N/A
Waitlist Available
Led By Kara Bragg, APRN, DNP
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing the IV SafeLock, a device that secures IV lines, in emergency department patients to ensure the lines stay in place and don't get accidentally disconnected.

Eligible Conditions
  • Intravenous Access

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Functionality of the IV SafeLock

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Emergency Department NursesExperimental Treatment1 Intervention
Registered nurses will use the IV SafeLock Device on patients during care in the emergency department.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
IV SafeLock
2023
N/A
~20

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,337 Previous Clinical Trials
3,061,154 Total Patients Enrolled
1 Trials studying Intravenous Access
169 Patients Enrolled for Intravenous Access
Kara Bragg, APRN, DNPPrincipal InvestigatorMayo Clinic
~9 spots leftby Nov 2025